Evidence map›Paper›PMID 25209250›Full record

ArticleDevelopment (Cambridge, England)2014

A regulatory network controls nephrocan expression and midgut patterning.

Juan Hou, Wei Wei, Ranajeet S Saund, Ping Xiang, Thomas J Cunningham, Yuyin Yi, Olivia Alder, Daphne Y D Lu, Joanne G A Savory, Nicole A J Krentz and 9 more

Open access · greenAbstract read
In one paragraph

Article in Development (Cambridge, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact, top 84% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Insight intoInternational journal of molecular sciences · 2019
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 2 countries.

Juan HouTerry Fox Laboratory, BC Cancer Agency, Vancouver, British Columbia, V5Z 1L3, Canada.
Wei WeiTerry Fox Laboratory, BC Cancer Agency, Vancouver, British Columbia, V5Z 1L3, Canada.
Ranajeet S SaundDepartment of Neurobiology and Anatomy, University of Utah, Salt Lake City, UT 84132-3401, USA.
Ping XiangTerry Fox Laboratory, BC Cancer Agency, Vancouver, British Columbia, V5Z 1L3, Canada.
Thomas J CunninghamDevelopment, Aging and Regeneration Program, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037, USA.
Yuyin YiTerry Fox Laboratory, BC Cancer Agency, Vancouver, British Columbia, V5Z 1L3, Canada Cell and Developmental Biology Program, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada.
Olivia AlderTerry Fox Laboratory, BC Cancer Agency, Vancouver, British Columbia, V5Z 1L3, Canada.
Daphne Y D LuTerry Fox Laboratory, BC Cancer Agency, Vancouver, British Columbia, V5Z 1L3, Canada.
Joanne G A SavoryCellular and Molecular Medicine, University of Ottawa, Ottawa K1H 8M5, Canada.
Nicole A J KrentzTerry Fox Laboratory, BC Cancer Agency, Vancouver, British Columbia, V5Z 1L3, Canada.
Rachel MontpetitTerry Fox Laboratory, BC Cancer Agency, Vancouver, British Columbia, V5Z 1L3, Canada.
Rebecca CullumTerry Fox Laboratory, BC Cancer Agency, Vancouver, British Columbia, V5Z 1L3, Canada.
Nicole HofsTerry Fox Laboratory, BC Cancer Agency, Vancouver, British Columbia, V5Z 1L3, Canada.
David LohnesCellular and Molecular Medicine, University of Ottawa, Ottawa K1H 8M5, Canada.
R Keith HumphriesTerry Fox Laboratory, BC Cancer Agency, Vancouver, British Columbia, V5Z 1L3, Canada Experimental Medicine, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada.
Yojiro YamanakaGoodman Cancer Research Centre, Department of Human Genetics, McGill University, Montreal, Quebec H2W 1S6, Canada.
Gregg DuesterDevelopment, Aging and Regeneration Program, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037, USA.
Yukio SaijohDepartment of Neurobiology and Anatomy, University of Utah, Salt Lake City, UT 84132-3401, USA.
Pamela A HoodlessTerry Fox Laboratory, BC Cancer Agency, Vancouver, British Columbia, V5Z 1L3, Canada Cell and Developmental Biology Program, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada hoodless@bccrc.ca.
BC Cancer Agency · CASanford Burnham Prebys Medical Discovery Institute · USUniversity of Ottawa · CAUniversity of Utah · USMcGill University · CAUniversity of British Columbia · CA

Funding

Generation of Retinoid Signals During DevelopmentR01GM062848 · NIGMS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI DUESTER, GREGG L · 2002 to 2015
$4.6M
The Roles of Definitive Endoderm in Establishment of Left-Right AsymmetryR01HD066121 · NICHD · UNIVERSITY OF UTAH · PI SAIJOH, YUKIO · 2010 to 2014
$1.5M
CIHR FRN 89806NICHD NIH HHS R01HD0066121NICHD NIH HHS R01 HD066121NIGMS NIH HHS GM062848NIGMS NIH HHS R01 GM062848
6 · The paper itself

Abstract

Although many regulatory networks involved in defining definitive endoderm have been identified, the mechanisms through which these networks interact to pattern the endoderm are less well understood. To explore the mechanisms involved in midgut patterning, we dissected the transcriptional regulatory elements of nephrocan (Nepn), the earliest known midgut specific gene in mice. We observed that Nepn expression is dramatically reduced in Sox17(-/-) and Raldh2(-/-) embryos compared with wild-type embryos. We further show that Nepn is directly regulated by Sox17 and the retinoic acid (RA) receptor via two enhancer elements located upstream of the gene. Moreover, Nepn expression is modulated by Activin signaling, with high levels inhibiting and low levels enhancing RA-dependent expression. In Foxh1(-/-) embryos in which Nodal signaling is reduced, the Nepn expression domain is expanded into the anterior gut region, confirming that Nodal signaling can modulate its expression in vivo. Together, Sox17 is required for Nepn expression in the definitive endoderm, while RA signaling restricts expression to the midgut region. A balance of Nodal/Activin signaling regulates the anterior boundary of the midgut expression domain.

Indexed as

ActivinsAldehyde OxidoreductasesAnimalsBody PatterningElectrophoretic Mobility Shift AssayEndodermGastrointestinal TractGene Expression Regulation, DevelopmentalGene Regulatory NetworksGenetic VectorsGlycoproteinsHMGB ProteinsIntercellular Signaling Peptides and ProteinsLuciferasesMiceMice, KnockoutActivinsAldehyde OxidoreductasesGlycoproteinsHMGB ProteinsIntercellular Signaling Peptides and ProteinsLuciferasesnephrocan protein, mouseRALDH2 protein, mouseReceptors, Retinoic AcidSox17 protein, mouseSOXF Transcription FactorsMidgut definitive endodermMouseNephrocan (Nepn)Nodal/Activin ARetinoic acidSox17

Identifiers

PMID25209250
PMCPMC4197584
OpenAlexW2325839971

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.